F7W-40315-17255
2 vaccinations
1 coded response
20 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 482 / MI
- Registered
- 2021-11-18
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Registered dependents
ASR-62071-19570
Child or adolescent in my care · Female · 2021-12-20
Timeline
-
2021-11-18
Registered in v-safe
-
2021-11-18
Dose 1 — Pfizer-BioNTech
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-12-02
- 2021-12-09
-
2021-12-15
Dose 2 — Pfizer-BioNTech
-
2021-12-16
Survey response — days 1–6 daily, dose 2MedDRA: Dehydration — Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: DehydratedMedDRA releases: 2024-11 · check-in free text available
- 2021-12-17
- 2021-12-18
- 2021-12-20
- 2021-12-21
- 2021-12-22
- 2021-12-29
- 2022-01-07
- 2022-01-12
- 2022-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-18 | Pfizer-BioNTech | No |
| 2 | 2021-12-15 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Dehydrated
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dehydration | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release